Skip to content

Clinical trials

Neurodevelopmental Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodevelopmental Disorders Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20171
20181
20192
20212
20222
20237
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting7
Active, not recruiting5
Unknown status3
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals3
St. Justine's Hospital3
University of Manitoba3
Holland Bloorview Kids Rehabilitation Hospital2
IWK Health Centre2
Taysha Gene Therapies, Inc.2
University of Alberta2
Anne Gallagher1
Emalex Biosciences Inc.1
McGill University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodevelopmental Disorders24
Autism Spectrum Disorder4
Epilepsy4
Mental Disorders4
Attention Deficit Disorder with Hyperactivity3
Seizures3
Cerebral Palsy2
Epilepsies, Myoclonic2
Lennox Gastaut Syndrome2
Neoplasms2

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.